Largest pharmaceutical companies in the United States by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 44 pharmaceutical companies in the United States ranked by total liabilities, at SEK 1.4T, ahead of Pfizer (SEK 1.24T) and Johnson & Johnson (SEK 1.2T). Figures as of 20 Nov 2026, 10:40 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- AbbVieSEK 1.4T
- Median
- SEK 8.5B
- Combined market value
- SEK 38.15T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SEK 1.4T | SEK 5.12T | SEK 2,895.40 | 0.86% down | 25% up | ||
| 2 | PfizerPFE · Health Care | SEK 1.24T | SEK 1.6T | SEK 281.23 | 1.85% down | 15% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | SEK 1.2T | SEK 6.57T | SEK 2,727.93 | 2.04% down | 34% up | ||
| 4 | Eli LillyLLY · Health Care | SEK 877.6B | SEK 12.29T | SEK 13,797.10 | 2.29% down | 33% up | ||
| 5 | Merck & CoMRK · Health Care | SEK 859.9B | SEK 3.34T | SEK 1,356.20 | 3.61% down | 45% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | SEK 730.5B | SEK 1.22T | SEK 595.74 | 2.05% down | 30% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | SEK 346.6B | SEK 1.84T | SEK 1,060.68 | 0.58% down | 16% down | ||
| 8 | ViatrisVTRS · Health Care | SEK 229.6B | SEK 232.7B | SEK 203.01 | 1.97% down | 99% up | ||
| 9 | ZoetisZTS · Health Care | SEK 123.9B | SEK 335.2B | SEK 825.00 | 5.59% down | 26% down | ||
| 10 | Royalty PharmaRPRX · Health Care | SEK 101.2B | SEK 397.6B | SEK 691.53 | 1.38% down | 79% up | ||
| 11 | Regeneron PharmaceuticalsREGN · Health Care | SEK 95B | SEK 975.4B | SEK 9,428.78 | 2.35% down | 28% up | ||
| 12 | Vertex PharmaceuticalsVRTX · Health Care | SEK 71.2B | SEK 1.35T | SEK 5,316.77 | 2.94% down | 27% up | ||
| 13 | Elanco Animal HealthELAN · Health Care | SEK 69.6B | SEK 134.2B | SEK 268.46 | 1.54% down | 26% up | ||
| 14 | Alnylam PharmaceuticalsALNY · Health Care | SEK 42.7B | SEK 202.2B | SEK 1,509.48 | 1.06% down | 66% down | ||
| 15 | Amneal PharmaceuticalsAMRX · Health Care | SEK 37.5B | SEK 76.1B | SEK 218.43 | 2.24% down | 90% up | ||
| 16 | PTC TherapeuticsPTCT · Health Care | SEK 31.7B | SEK 49.8B | SEK 595.59 | 3.16% down | 21% down | ||
| 17 | Ionis PharmaceuticalsIONS · Health Care | SEK 31B | SEK 46.3B | SEK 277.96 | 0.62% down | 63% down | ||
| 18 | BridgeBio PharmaBBIO · Health Care | SEK 30.8B | SEK 155.5B | SEK 798.34 | 0.22% up | 21% up | ||
| 19 | CytokineticsCYTK · Health Care | SEK 21.3B | SEK 73.2B | SEK 525.49 | 0.27% up | 19% down | ||
| 20 | InsmedINSM · Health Care | SEK 15.6B | SEK 323.6B | SEK 1,475.17 | 20.58% up | 40% down | ||
| 21 | BioMarin PharmaceuticalBMRN · Health Care | SEK 15.4B | SEK 121.5B | SEK 627.20 | 0.02% down | 17% up | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 9B | SEK 63B | SEK 445.74 | 1.25% up | 13% up | ||
| 23 | United TherapeuticsUTHR · Health Care | SEK 8B | SEK 243.2B | SEK 5,709.31 | 3.16% down | 22% up | ||
| 24 | Legend BiotechLEGN · Health Care | SEK 7.5B | SEK 31.9B | SEK 164.41 | 0.92% down | 41% down | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 6.7B | SEK 94.1B | SEK 4,051.35 | 0.34% down | 27% down | ||
| 26 | Axsome TherapeuticsAXSM · Health Care | SEK 6.1B | SEK 72.9B | SEK 1,385.51 | 1.25% up | 6% down | ||
| 27 | Ligand PharmaceuticalsLGND · Health Care | SEK 5.5B | SEK 58.6B | SEK 2,930.12 | 3.94% down | 50% up | ||
| 28 | Mirum PharmaceuticalsMIRM · Health Care | SEK 5.4B | SEK 63.7B | SEK 975.31 | 3.27% up | 34% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | SEK 5B | SEK 47.3B | SEK 493.22 | 3.86% down | 45% up | ||
| 30 | TG TherapeuticsTGTX · Health Care | SEK 4.2B | SEK 100.1B | SEK 662.53 | 1.88% down | 117% up | ||
| 31 | Cogent BiosciencesCOGT · Health Care | SEK 3.1B | SEK 49.3B | SEK 283.27 | 0.25% down | 20% down | ||
| 32 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 2.1B | SEK 82.7B | SEK 1,192.71 | 1.88% down | 18% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | SEK 1.9B | SEK 72.6B | SEK 663.55 | 4.15% down | 10% down | ||
| 34 | Definium TherapeuticsDFTX · Health Care | SEK 1.1B | SEK 41.2B | SEK 301.04 | 1.24% up | 168% up | ||
| 35 | Summit TherapeuticsSMMT · Health Care | SEK 942.8M | SEK 86.3B | SEK 107.94 | 0.67% up | 36% down | ||
| 36 | ErascaERAS · Health Care | SEK 724.9M | SEK 51B | SEK 145.21 | 3.34% up | 395% up | ||
| 37 | Spyre TherapeuticsSYRE · Health Care | SEK 638.7M | SEK 94.7B | SEK 996.96 | 3.77% down | 332% up | ||
| 38 | Praxis Precision MedicinesPRAX · Health Care | SEK 610.4M | SEK 88.7B | SEK 3,174.79 | 1.87% up | 86% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | SEK 546.1M | SEK 82.7B | SEK 1,266.44 | 2.47% down | 51% up | ||
| 40 | Dianthus TherapeuticsDNTH · Health Care | SEK 383.1M | SEK 48.8B | SEK 866.25 | 1.01% up | 108% up | ||
| 41 | Edgewise TherapeuticsEWTX · Health Care | SEK 309.9M | SEK 46B | SEK 420.41 | 0.48% down | 86% up | ||
| 42 | Oruka TherapeuticsORKA · Health Care | SEK 170.4M | SEK 67.6B | SEK 996.35 | 1.91% up | 255% up | ||
| 43 | Belite BioBLTE · Health Care | SEK 102.8M | SEK 62.6B | SEK 1,542.16 | 3.33% down | 43% up | ||
| 44 | VeradermicsMANE · Health Care | SEK 93.5M | SEK 53.6B | SEK 1,270.22 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 10.2116 SEK).
Questions and answers
Which pharmaceutical companies in the United States rank first by total liabilities?
AbbVie (SEK 1.4T), Pfizer (SEK 1.24T) and Johnson & Johnson (SEK 1.2T) are the top three of the 44 pharmaceutical companies in the United States ranked by total liabilities as of 20 Nov 2026, 10:40 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total liabilities.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total liabilities have a combined market value of SEK 38.15T as of 20 Nov 2026, 10:40 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total liabilities”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.